Friday, July 10, 2026

pharma · Allergies · Early Parkinson Disease

Advanced Accelerator Applications

Advanced Accelerator Applications is a pharma organization headquartered in RUEIL-MALMAISON, FR. Primary therapeutic focus areas include Allergies, Early Parkinson Disease, Breast Cancer, Recurrent or Metastatic Breast C

20 rue Diesel, Saint Genis Pouilly, 01630, FR, RUEIL-MALMAISON HQ
590 Employees
EMA registrant Type
Company details
Status
Public
HQ
20 rue Diesel, Saint Genis Pouilly, 01630, FR, RUEIL-MALMAISON
Employees
590
Programs
12
Drugs
25
Patents
25
Clinical program

API-EAL-2024-01

Phase 2 · small molecule · Allergies

API-EAL-2024-01 for Allergies is a Phase 2 program (small_molecule) at Advanced Accelerator Applications with 1 ClinicalTrials.gov record(s).

Internal code API-EAL-2024-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Advanced Accelerator Applications
Phase
Phase 2
Modality
small_molecule
Indication
Allergies
Status
active
Trials
1

Clinical trials